Summary:
In today's environment, volatility is the norm. Health systems face margin fragility, rising expenses, consumer affordability challenges, policy disruptions, payer retrenchment, and rapid site-of-care shifts that are reshaping strategic footing. This session unpacks those pressures — helping you understand the assumptions health systems are rethinking. We then focus on the levers that will define health system success, including asset-light growth models, operational efficiency that unlocks capacity and revenue, and workforce modernization aligned with AI-enabled productivity. Grounded in the latest Academy data, member conversations, and market sensing, this session equips you with a sharper read on where health systems are headed in 2026 and how to align your commercial strategy accordingly.
Please log in to view the full recording and access downloadable materials.
Key takeaways:
1) Health systems can't just cut costs — they have to redesign the enterprise
Margins remain structurally thin, and incremental cuts won't stabilize performance. Health systems are being forced into structural redesign — shifting sites of care, rethinking workforce models, integrating digital workflows, and rebuilding cost structures for a lower-revenue world.
What this means for industry partners: Partners that position around point solutions or departmental wins will struggle. Systems will need partners who can support enterprise-level redesign. The buying lens is system transformation, not feature enhancement.
2) Site-of-care shift is not optional — it's policy-accelerated
Revenue migration to ambulatory, ASC, and virtual settings is being driven by reimbursement reform and payer pressure — not just consumer preference. Systems with stronger ASC and ambulatory footprints are outperforming on margin, and capital is flowing accordingly.
What this means for industry partners: Winning partners will help systems scale asset-light growth models — ambulatory platforms and digital platforms. Solutions tied only to hospital-based volume are increasingly exposed to structural risk.
3) AI investment is real — but ROI is the gating factor
AI is scaling across documentation, access, revenue cycle, and throughput, with a modeled $174M opportunity in a $5B system. But executives are clear: AI that does not convert efficiency into measurable revenue lift will stall.
What this means for industry partners: Health systems are looking for partners who can connect automation to capacity redeployment and measurable financial impact. The competitive advantage will belong to those who can demonstrate how AI translates into margin protection and growth — not just cost cuts.